With the threat of Trump administration's tariffs swirling and biopharma companies bracing for impact, many are announcing ...

Following in the footsteps of several pharma companies, life sciences giant Thermo Fisher is doubling down on investments at ...

The science-services and instruments provider is expanding operations in the U.S. as companies rearrange manufacturing to avoid new global tariffs. The pharmaceutical industry has long been exempt ...

In recent days, Boston Scientific announced a forthcoming CFO change, a Cambridge biotech undertook a 1-for-20 reverse stock ...

Medical equipment maker Thermo Fisher Scientific on Wednesday cut its annual profit forecast, in anticipation of a potential ...

QUT researchers have identified a new material which could be used as a flexible semiconductor in wearable devices by using a ...

Thermo Fisher CEO Marc Casper noted strong performance in Q1 2025, delivering $10.36 billion in revenue. Adjusted EPS grew 1% to $5.15. Adjusted operating income was $2.27 billion, with an adjusted ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

In this article, we are going to take a look at where Thermo Fisher Scientific Inc. (NYSE:TMO) stands against other profitable dividend stocks. Amid growing concerns about economic growth and ...